|
Isotope hydrology research in Canada, 2003-2007.(Report)
|
Introduction
The utility of isotope techniques in hydrological investigations stems from their ability to label water sources and cycling processes including surface/ groundwater interaction, water residence times, flow pathways, evaporation fluxes, and solute processes, to name a few. The stable isotopes of water ([H.sub.2] [sup.18]O, [sup.2]H) are most commonly employed as tracers as they are incorporated within the water molecule ([H.sub.2] [sup.18]0, [sup.1]H [sup.2]H[sup.16]O) and because they undergo measureable and systematic fractionations as they move ...
|
Regulus Announces Wells Fargo as First 'Certified Bank' For Check Conversion.
PR Newswire
; ...PHILADELPHIA, Sept. 15 /PRNewswire/ -- Regulus, the nation's premier Document and Remittance...financial services company to complete the Regulus bank certification process for Check Conversion. Regulus' bank certification program solidifies...
|
|
Regulus Therapeutics Achieves Initial Milestone in its Inflammatory Diseases Collaboration with GlaxoSmithKline.
Business Wire
; ...in immune cells CARLSBAD, Calif. -- Regulus Therapeutics Inc. today announced that...targets related to inflammatory disease. Regulus has now reached an important discovery...Ph.D., Chief Scientific Officer at Regulus. "We believe that we are the leaders...
|
|
Regulus Therapeutics Receives $20 Million in a Series A Equity Financing.
Business Wire
; ...Calif. & CAMBRIDGE, Mass. -- Regulus Therapeutics Inc., Alnylam Pharmaceuticals...Nasdaq:ISIS) announced today that Regulus has raised $20 million in a Series A...and equal investors in the financing. Regulus was established in September of 2007 by...
|
|
Regulus Therapeutics Receives $20 Million in a Series a Equity Financing.
Newspaper article from: Biotech Week
; Regulus Therapeutics Inc., Alnylam Pharmaceuticals...Inc. (Nasdaq:ISIS) announced that Regulus has raised $20 million in a Series A preferred...and equal investors in the financing. Regulus was established in September of 2007 by...
|
|
Regulus Therapeutics Appoints Hubert C. Chen, M.D., Vice President of Translational Medicine.
Business Wire
; CARLSBAD, Calif. -- Regulus Therapeutics Inc., a leading microRNA...President of Translational Medicine. At Regulus, Dr. Chen will be responsible for...expertise to the ongoing efforts at Regulus as we continue to lead the field in...
|
|
Regulus Therapeutics Appoints Garry Menzel, Ph.D., as Executive Vice President Corporate Development and Finance.
Business Wire
; ...Play an Important Role in the Growth of Regulus CAMBRIDGE, Mass. & CARLSBAD, Calif. -- Regulus Therapeutics LLC, a joint venture between...global biotechnology finance practices to Regulus. "We are delighted to welcome Garry to...
|
|
Regulus, Alnylam, and Isis Announce First microRNA Patent Grant in Japan from Tuschl III Patent Series.
Business Wire
; ...Calif. & CAMBRIDGE, Mass. -- Regulus Therapeutics Inc., Alnylam Pharmaceuticals...is a leading pre-clinical program at Regulus. The grant of this first Tuschl III patent...858) performed by Alnylam founder and Regulus scientific advisory board member Dr...
|
|
US Dataworks and OPEX Corporation Proudly Announce Regulus as the First Installation of ZeroPass(TM).
PR Newswire
; ...processing equipment proudly announce Regulus, one of the nation's premier Content...hardware and US Dataworks software, gives Regulus the ability to open, extract, sort and...noted Kathy Hamburger, President of Regulus. "We are proud to be one of the pioneers...
|
|
US Dataworks and OPEX Announce Regulus as Nation's First System with ZeroPass(TM) in Production.
PR Newswire
; ...processing equipment proudly announced Regulus, one of the nation's premier Remittance...hardware and US Dataworks software, gives Regulus the ability to open, extract, decision...privilege to partner with US Dataworks and Regulus in taking ZeroPass(TM) from concept...
|
|
Regulus Therapeutics Appoints Kleanthis G. Xanthopoulos, Ph.D. as President and Chief Executive Officer.
Business Wire
; ...Mass. & CARLSBAD, Calif. -- Regulus Therapeutics LLC, a joint venture between...John Maraganore, Ph.D., Chairman of Regulus, and President and Chief Executive Officer...are delighted that Kleanthis has joined Regulus," said Stanley Crooke, M.D., Ph...
|
Find more facts and information related to the
article "Isotope hydrology research in Canada, ..."